-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
HIV resistance has always been an important factor affecting AIDS treatment.
In this issue, I will share with you an article published on "Open Forum Infectious Diseases" on April 22, 2022, to take us to understand the real drug resistance situation in African countries after antiretroviral therapy
Article Review
Many countries in sub-Saharan Africa started dolutegravir-based antiretroviral therapy in 2019 as the first-line treatment option for adults starting treatment, and have already switched other regimens to dolutegravir in transitional populations
By the end of March 2021, 838,000 Malawians in the national program had received a dolutegravir-based regimen; viral loads remained greater than 1000 copies/mL after 3 months of intensive adherence support in patients, according to Malawi HIV guidelines may conduct drug resistance testing
Systematic data from November 2020 to August 2021 indicated that 6462 patients with virological failure were eligible for HIV drug resistance testing
Result analysis
Only 87 were submitted to the National Drug Resistance Committeelook back global
The report shows that the level of HIV drug resistance has risen steadily in recent years as HIV drug use continues to increase
It also pointed out that HIV drug resistance has a significant impact on AIDS deaths, new infections and treatment costs.
look at China
Source of part of the content of the literature: Youai Classroom